CD8 regulatory T cell therapy in transplantation: a new path to clinical success?

Yannick D. Muller, Julien Zuber · 2026

Read CD8 regulatory T cell therapy in transplantation: a new path to clinical success? by Yannick D. Muller, Julien Zuber (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13286856.txt.

Description

Yannick D. Muller and Julien Zuber review a new cell therapy aimed at calming the immune system after organ transplantation, using a less-studied class of regulatory T cells marked CD8. Published in 2026, the article sets this approach beside the better-known CD4 regulatory cells already in many transplant trials. A first-in-human trial, Eight-Treg, is testing the CD8 version in kidney recipients.

The cells are sorted from a candidate's own blood before transplant, grown for three weeks under conditions that preserve their calming identity, and returned as a living product. Earlier CD4 trials hinted that such therapy can safely reduce anti-rejection drug doses. Whether the CD8 route reaches routine care depends on trial results still to come.

Catalog record

CREATORYannick D. Muller, Julien Zuber
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13286856

Browse the full library · About the Tower of Babel